WuXi XDC Cayman (FRA:L74) Owner Earnings per Share (TTM): 0.11 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:L74 WuXi XDC Cayman Inc FRA:L74
55 GF Score
Price €7.65
! 3 Warning Signs
View Full Analysis

What is WuXi XDC Cayman Owner Earnings per Share (TTM)?

WuXi XDC Cayman FRA:L74 +2.00% 55 Owner Earnings per Share (TTM) is 0.11 as of Dec. 2025. GuruFocus rates FRA:L74 with a GF Score™ of 55/100. The stock has 3 warning signs investors should review. Among 73 Medical Diagnostics & Research companies, WuXi XDC Cayman ranks worse than 86.3% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

WuXi XDC Cayman's Owner Earnings per Share (TTM) ended in Dec. 2025 was €0.11. It's Price-to-Owner-Earnings ratio for today is 69.55.


The historical rank and industry rank for WuXi XDC Cayman's Owner Earnings per Share (TTM) or its related term are showing as below:

FRA:L74' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 47.65   Med: 72.91   Max: 182.23
Current: 72.55


During the past 6 years, the highest Price-to-Owner-Earnings ratio of WuXi XDC Cayman was 182.23. The lowest was 47.65. And the median was 72.91.


FRA:L74's Price-to-Owner-Earnings is ranked worse than
86.3% of 73 companies
in the Medical Diagnostics & Research industry
Industry Median: 26.46 vs FRA:L74: 72.55

WuXi XDC Cayman's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was €0.07. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.14. It's PE Ratio (TTM) ratio for today is 53.13.

WuXi XDC Cayman's EPS without NRI for the six months ended in Dec. 2025 was €0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.17. It's PE Ratio without NRI ratio for today is 46.36.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


WuXi XDC Cayman Owner Earnings per Share (TTM) Related Terms


WuXi XDC Cayman Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for WuXi XDC Cayman's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WuXi XDC Cayman Owner Earnings per Share (TTM) Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial 0.00 0.00 0.00 0.06 0.11

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.06 0.00 0.11 0.00

FRA:L74 vs TMO, DHR, NTRA: Owner Earnings per Share (TTM) Comparison

For the Diagnostics & Research subindustry, WuXi XDC Cayman's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WuXi XDC Cayman Price-to-Owner-Earnings vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where WuXi XDC Cayman's Price-to-Owner-Earnings falls into.


FRA:L74
55GF Score
WuXi XDC Cayman Inc FRA:L74
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WuXi XDC Cayman Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

WuXi XDC Cayman's Owner Earnings per Share (TTM) Calculation:

Last Year Average of Last 5 Years
Net Income 179.5
Depreciation, Depletion and Amortization 17.9
Change In Deferred Tax 0.0
5Y Average of Maintenance Capital Expenditure 56.5
Change In Working Capital -0.2
Shares Outstanding (Diluted Average) 1,325.8

1. Start with "Net Income" from income statement. WuXi XDC Cayman's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was €179.5 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. WuXi XDC Cayman's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Dec. 2025 was €17.9 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. WuXi XDC Cayman's Change In Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = €56.5 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

WuXi XDC Cayman's 5-Year Average Maintenance Capital Expenditure = €56.5 Mil

5. "Change In Working Capital" is from cashflow statement. WuXi XDC Cayman's Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.2 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. WuXi XDC Cayman's Shares Outstanding (Diluted Average) for the months ended in Dec. 2025 was 1325.831 Mil.

WuXi XDC Cayman's Onwer Earnings Per Share for Dec. 2025 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 179.513 +17.905+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-56.548+-0.224)/1325.831
=0.11

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=7.65/0.11
=69.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 0.11 mean?
WuXi XDC Cayman (FRA:L74) has a Owner Earnings per Share (TTM) of 0.11 as of Dec. 2025. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on WuXi XDC Cayman. According to the industry distribution chart, WuXi XDC Cayman ranks #63 out of 73 companies in the Medical Diagnostics & Research industry, placing it in the top 86.3%.
Is WuXi XDC Cayman's Owner Earnings per Share (TTM) too high?
WuXi XDC Cayman's current Owner Earnings per Share (TTM) is 0.11. The Medical Diagnostics & Research industry median Owner Earnings per Share (TTM) is 26.46. WuXi XDC Cayman's value of 0.11 is 99.6% below this industry median. Based on the distribution chart, WuXi XDC Cayman ranks #63 out of 73 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, WuXi XDC Cayman has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does WuXi XDC Cayman's Owner Earnings per Share (TTM) compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, WuXi XDC Cayman ranks #63 out of 73 companies for Owner Earnings per Share (TTM). This places WuXi XDC Cayman in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 26.46. WuXi XDC Cayman's value of 0.11 is 99.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Medical Diagnostics & Research company?
The median Owner Earnings per Share (TTM) among Medical Diagnostics & Research companies is 26.46, based on 73 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WuXi XDC Cayman's current Owner Earnings per Share (TTM) of 0.11 is 99.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on WuXi XDC Cayman. For the Medical Diagnostics & Research industry, the median Owner Earnings per Share (TTM) is 26.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WuXi XDC Cayman's current Owner Earnings per Share (TTM) is 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WuXi XDC Cayman stock overvalued right now?
WuXi XDC Cayman (FRA:L74) has a current Owner Earnings per Share (TTM) of 0.11. The current Owner Earnings per Share (TTM) is 0.11 and 99.6% below the Medical Diagnostics & Research industry median of 26.46. WuXi XDC Cayman's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For WuXi XDC Cayman (FRA:L74), the current Owner Earnings per Share (TTM) is 0.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

WuXi XDC Cayman Business Description

Other Exchanges 02268:Hong Kong
Address No. 11 Xinhui Ring Road, Xinwu, Jiangsu Province, Wuxi, CHN
WuXi XDC Cayman Inc is a CRDMO focused on the ADC and broader bioconjugate market and is the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, it offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development, and manufacturing. The company provides these services from proximately located laboratories and manufacturing facilities, resulting in the reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development, and manufacturing platform, its mission is to continuously enhance its platform and propel and transform the development of the bioconjugate industry.
55GF Score

Get the complete analysis for FRA:L74

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.65
Price